Brief: Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products And Molecule Stabilizing Technology Franchise From Vyne Therapeutics
13/01/2022 12:13
Jan 13 (Reuters) - Journey Medical Corp DERM.O :
* JOURNEY MEDICAL CORPORATION ACQUIRES TWO FDA-APPROVED TOPICAL MINOCYCLINE
PRODUCTS AND MOLECULE STABILIZING TECHNOLOGY FRANCHISE FROM VYNE THERAPEUTICS
* JOURNEY MEDICAL CORP - EAST WEST BANK CREDIT AGREEMENT EXPANDED TO $30.0
MILLION
* JOURNEY MEDICAL CORP - TO ACQUIRE MOLECULE STABILIZING TECHNOLOGY
FRANCHISE FOR
AN UPFRONT PAYMENT OF $20.0 MILLION
* JOURNEY MEDICAL CORP - TRANSACTION CLOSED SIMULTANEOUSLY WITH SIGNING.
Source text for Eikon: ID:nGNX6VHcJ7
Further company coverage: DERM.O
Recent news on Journey Medical
See all newsJourney Medical Corp expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies